Send us Feedback

Neurogen (NRGN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Inergy, L.P. (NRGY), Inergy Midstream (NRGN) Announce FY13 Net Income, EBITDA Outlook
StreetInsider.com  Dec 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Inergy%2C+L.P.+%28NRGY%29%2C+Inergy+Midstream+%28NRGN%29+Announce+FY13+Net+Income%2C+EBITDA+Outlook/7916518.html for the full story.
(LGND) Ligand Pharmaceuticals to Buy Neurogen
Stock Blog Hub  Aug 25  Comment 
Yesterday, Ligand Pharmaceuticals Inc. (LGND) announced it has agreed to purchase Neurogen (NRGN) for $11 million in stock as well as certain future cash payments based on licensing deals, real estate sales and other milestones. The deal, which...
Ligand strikes deal to buy struggling Neurogen
FierceBiotech  Aug 25  Comment 
Three months after slashing half of its workforce and shelving research work, Neurogen has agreed to be bought out by Ligand Pharmaceuticals for $11 million in stock and the chance to earn millions more in milestones. The acquisition deal gives...
Neurogen suspends enrollment, cuts staff
FierceBiotech  May 12  Comment 
Psychiatric and neurological drug developer Neurogen says it has suspended the enrollment of additional patients in its ongoing Phase II studies for Parkinson's disease and Restless Legs Syndrome, as well as eliminated half its staff. The company...




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Neurogen_(NRGN)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki